{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:17:54Z","timestamp":1793276274278,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jaad.2016.02.1239","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:20:38Z","timestamp":1481674838000},"page":"11-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Prevention and management of glucocorticoid-induced side effects: A comprehensive review"],"prefix":"10.1016","volume":"76","author":[{"given":"Avrom","family":"Caplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.02.1239_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":"Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM198307073090105","article-title":"Association of adrenocorticosteroid therapy and peptic-ulcer disease","volume":"309","author":"Messer","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib3","first-page":"A5540","article-title":"Concomitant use of proton pump inhibitors and systemic corticosteroids","volume":"157","author":"Dorlo","year":"2013","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.jaad.2016.02.1239_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","article-title":"Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs","volume":"114","author":"Piper","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib5","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.1993.03500160080036","article-title":"Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial","volume":"269","author":"Chrousos","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2016.02.1239_bib6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.110.973008","article-title":"Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications","volume":"123","author":"Garc\u00eda Rodr\u00edguez","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2016.02.1239_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib8","doi-asserted-by":"crossref","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","article-title":"Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis","volume":"4","author":"Narum","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaad.2016.02.1239_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/aje\/153.11.1089","article-title":"Steroids and risk of upper gastrointestinal complications","volume":"153","author":"Hern\u00e1ndez-D\u00edaz","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaad.2016.02.1239_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/jamainternmed.2013.2737","article-title":"Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study","volume":"173","author":"Sadr-Azodi","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10067-003-0793-3","article-title":"Systemic lupus erythematosus and acute pancreatitis: a case series","volume":"23","author":"Derk","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2016.02.1239_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MCG.0b013e3182333820","article-title":"Recent safety concerns with proton pump inhibitors","volume":"46","author":"Chen","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jaad.2016.02.1239_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MED.0000000000000031","article-title":"Proton pump inhibitor therapy and potential long-term harm","volume":"21","author":"Corleto","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jaad.2016.02.1239_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jaad.2016.02.1239_bib16","unstructured":"US Food and Drug Administration website. The FDA Safety Information and Adverse Event Reporting Program. Available at: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/ucm225843.htm. Accessed January 23, 2015."},{"key":"10.1016\/j.jaad.2016.02.1239_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0889-8529(05)70271-1","article-title":"Diabetes management in special situations","volume":"26","author":"Hirsch","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jaad.2016.02.1239_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.1994.00420010131015","article-title":"Glucocorticoids and the risk for initiation of hypoglycemic therapy","volume":"154","author":"Gurwitz","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib19","doi-asserted-by":"crossref","first-page":"c54","DOI":"10.1159\/000097598","article-title":"Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases","volume":"105","author":"Uzu","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jaad.2016.02.1239_bib20","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2010-2729","article-title":"Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD","volume":"96","author":"Burt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2016.02.1239_bib21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/pgmj.63.743.761","article-title":"Alternate day corticosteroid causes alternate day hyperglycaemia","volume":"63","author":"Greenstone","year":"1987","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaad.2016.02.1239_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/pgmj.40.469.660","article-title":"Clinical features of the diabetic syndrome appearing after steroid therapy","volume":"40","author":"Miller","year":"1964","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaad.2016.02.1239_bib23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s12098-008-0208-1","article-title":"Corticosteroid physiology and principles of therapy","volume":"75","author":"Gupta","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jaad.2016.02.1239_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1210\/jc.2005-2737","article-title":"Editorial: glucocorticoid replacement\u2014how much is enough?","volume":"91","author":"Lukert","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2016.02.1239_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2016.02.1239_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MED.0b013e328338f608","article-title":"Adrenal insufficiency: etiology, diagnosis and treatment","volume":"17","author":"Neary","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jaad.2016.02.1239_bib27","series-title":"Current therapy in endocrinology and metabolism","first-page":"113","article-title":"Corticosteroid withdrawal","author":"Christy","year":"1988"},{"key":"10.1016\/j.jaad.2016.02.1239_bib28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0002-9343(78)90510-7","article-title":"Alternate-day corticosteroid therapy","volume":"64","author":"Fauci","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1056\/NEJM196802222780801","article-title":"Adrenocortical responsiveness after alternate-day corticosteroid therapy","volume":"278","author":"Ackerman","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejim.2013.05.014","article-title":"Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself","volume":"24","author":"Dinsen","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJM199201233260403","article-title":"The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone","volume":"326","author":"Schlaghecke","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-8-1","article-title":"Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"8","author":"Schuetz","year":"2008","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaad.2016.02.1239_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0889-8529(02)00008-7","article-title":"Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review","volume":"31","author":"Richter","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jaad.2016.02.1239_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2016.02.1239_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ecl.2005.01.013","article-title":"Exogenous Cushing's syndrome and glucocorticoid withdrawal","volume":"34","author":"Hopkins","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jaad.2016.02.1239_bib36","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/ard.2007.072157","article-title":"EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases","volume":"66","author":"Hoes","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2016.02.1239_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11926-016-0595-7","article-title":"Stress dose steroids: Myths and perioperative medicine","volume":"18","author":"MacKenzie","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaad.2016.02.1239_bib38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221630041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221630041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:40:02Z","timestamp":1759272002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221630041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S019096221630041X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1239","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and management of glucocorticoid-induced side effects: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(16)31128-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc. Published by Elsevier. All rights reserved.","name":"copyright","label":"Copyright"}]}}